CYP — Cynata Therapeutics Share News
0.000.00%
Last trade - 00:00- AU$4.02m
- AU$3.12m
- AU$0.08m
Australia Stock Exchange release from CYNATA THR : Progress Toward Clinical Trial in Diabetic Foot Ulcers
Australia Stock Exchange release from CYNATA THR : PRE_NR Ends: 09:31:50
Australia Stock Exchange release from CYNATA THR : Cynata to Present at MST Access Investor Conference 15 June
Brief: Cynata Signs Licence Agreement With Tekcyte To Advance Clinical Trial In Diabetic Foot Ulcers
Australia Stock Exchange release from CYNATA THR : Release of Securities from Voluntary Escrow
Brief: First Patient Enrolled In Cynata’s Mend Clinical Trial
Australia Stock Exchange release from CYNATA THR : First Patient Enrolled in Cynata MEND Clinical Trial
Australia Stock Exchange release from CYNATA THR : PRE_NR Ends: 12:21:02
Australia Stock Exchange release from CYNATA THR : Quarterly Activity Report & Appendix 4C
Australia Stock Exchange release from CYNATA THR : PRE_NR Ends: 09:26:18
Brief: Cynata Says Expanded MEND Clinical Trial In COVID-19 And Respiratory Failure
Australia Stock Exchange release from CYNATA THR : Cynata Expands trial in COVID-19 & Respiratory Failure
Australia Stock Exchange release from CYNATA THR : PRE_NR Ends: 09:54:07
Australia Stock Exchange release from CYNATA THR : Cynata Investor Presentation
Australia Stock Exchange release from CYNATA THR : New Study to Investigate the High Potency of Cymerus MSCs
Brief: Cynata Advances Planned Clinical Trial In Diabetic Foot Ulcers In MoU With Tekcyte
Australia's Cynata Therapeutics rises on TekCyte deal
Australia Stock Exchange release from CYNATA THR : Cynata Advances Planned Clinical Trial in DFU with TekCyte
Australia Stock Exchange release from CYNATA THR : PRE_NR Ends: 18:06:25